Literature DB >> 33613063

Phytochemical composition and in vitro biological activities of Morinda citrifolia fruit juice.

Haziz Sina1, Gado Dramane2, Philippe Tchekounou1, Mahoudo Fidèle Assogba3, Kamirou Chabi-Sika1,4, Bawa Boya1, Akim Socohou1, Adolphe Adjanohoun5, Lamine Baba-Moussa1.   

Abstract

Morinda citrifolia is a plant with broad nutraceutical and therapeutic effects and used in the traditional treatment of several ailments. The objective of this work is to investigate the phytochemistry of the fruit juice of M. citrifolia on one hand and on other hand to evaluate its antiradical and antibacterial activity. The phytochemical investigation was carried out by tube staining tests of the extract of two types of fruit juice of M. citrifolia. The antioxidant activity of these juices was evaluated by reducing the DPPH radical method. Concerning the antibacterial activity, it was tested on the in vitro growth of 10 reference bacterial strains using the well diffusion method. Qualitative phytochemistry of M. citrifolia fruit juices revealed the presence of large groups of secondary metabolites including polyphenols, reducing compounds, mucilage and terpernoids. The antioxidant activity of M. citrifolia fruit juices is dose-dependent and higher than that of ascorbic acid. Antimicrobial activity on other hand revealed that fruit juices inhibit growth inhibitory activity of Staphylococcus aureus, Pseudomonas aeruginosa, Proteus mirabilis, S. epidermidis, Proteus vulgaris, Streptococcus oralis, Enterococcus faecalis and Escherichia coli. This observed difference is significant for each juices on the strains (p < 0.001). These results support the use of M. citrifolia in traditional medicine and are the starting points for the development of a new drug to combat both dietary conditions and chronic conditions associated with oxidative stress.
© 2020 The Authors.

Entities:  

Keywords:  Antibacterial activities; Fermentation; M. citrifolia; Phytochemical screening

Year:  2020        PMID: 33613063      PMCID: PMC7878717          DOI: 10.1016/j.sjbs.2020.11.059

Source DB:  PubMed          Journal:  Saudi J Biol Sci        ISSN: 2213-7106            Impact factor:   4.219


Introduction

In developing countries, the socio-economic context makes it more difficult to manage the health status of the people living. However, infectious diseases cause more than 17 million deaths a year worldwide, more than half of them on the African continent (Traoré et al., 2012). Populations commonly use of medicinal plants to control diseases (Bessong et al., 2006). These medicinal plants produce various types of bioactive molecules, making them sources of different types of potential drugs (Walton and Brown, 1999, Ghasemzadeh et al., 2010). Indeed, medicinal plants are a valuable heritage for humanity and in particular, for the majority of poor communities in developing countries who depend on them for their primary health care and livelihoods (Salhi et al., 2010). This is not only due to the low economic resources of the populations in these countries that limit the purchase of pharmaceuticals, but also the ineffectiveness of some synthetic drugs (Conlon et al., 2003). Thus, several plants are good sources of therapeutic agents and are traditionally used for different purposes, including treatments against bacteria, fungi and viruses (Bessong et al., 2006). Morinda citrifolia is one of these plants with wide nutraceutical and therapeutic effects, known for its medicinal values since 2000 years in Asia and Australia (Whistler, 1985). It is a tropical and subtropical plant grown on the Pacific Islands and has been used to treat about 2000 diseases (Mc Clatchey, 2002). It is used as antifungal, antibacterial, anti-inflammatory, anticancer, antiparasitic, analgesic (Calzuola et al., 2006, Wang et al., 2002, Jasril et al., 2003, Pawlus et al., 2005, Potterat and Hamburger, 2007, Ruksilp et al., 2011). The juice extracted from the fruit is marketed under the name “Noni” as a dietary supplement in the USA (Phakhodee, 2012). This plant, recently introduced in Benin, is recommended in the treatment of several ailments such as cough, skin infections, urinary tract infections, tuberculosis, etc. Natural pure juices (fresh or fermented), without water addition, are often used. Nevertheless, there is very little scientific evidence supporting the therapeutic values of M. citrifolia juice. Thus, this work aimed to do the phytochemical screening and evaluate the antioxidant and antibacterial activities of the fruits of Morinda citrifolia.

Material and methods

Collecting and obtaining of Morinda citrifolia juices

The fruits of M. citrifolia were harvested two times (May and July) in the Mono Department (Benin). The juices obtained in May 2019 were considered as fermented juice, whereas the fresh juice was in July 2019. Commercial noni juice is traditionally produced by fermentation of noni fruits in a sealed container for 2 months at room temperature (Nelson, 2006). Direct pressing of noni fruit produces Noni fresh juice. Thus, fresh noni juice is obtained by direct pressing of 500 g M. citrifolia fruits in tightly closed jars. The fermented fruit juice was obtained by introducing 500 g of fruit into a sealed container for at least two months at room temperature. In both cases, the resulting juice was filtered on cotton and then on wattman paper.

Phytochemical profiling

Tube staining tests described by Houghton et al. (1998) identified the chemical groups contained in the aqueous raw extracts of leaves and fruit juice extracts of Morinda citrifolia.

Evaluation of anti-radical activity

The anti-radical activity of our extracts was evaluated by the DPPH (2,2-diphenyl-1picrylhydrazyl) method using the procedure previously described by Lamien-Meda et al. (2008). For this test, the samples were prepared by dissolution in distilled water (Panichayupakaranant and Kaewsuwan, 2004). Each stock solution is diluted in reason 2 geometric series to have a concentration range from 0.8 to 0.003125 mg / ml. In dry and sterile test tubes, 1 ml of the extract solution to be tested is introduced, added to 1 ml of the DPPH solution (4%). After stirring in the vortex, the tubes are then placed away from the light at room temperature for 15 min. Absorbance was read at 517 nm at the spectrophotometer (UV/VIS). For each dilution, a blank was prepared under the same conditions. The anti-radical activity of the extracts was determined by determining for each extract, the effective concentration of the substrates reducing by 50% the activity of DPPH (EC50) then compared to that of ascorbic acid (0.8–0.003125 mg/ml).

Evaluation of the antibacterial activity of M. citrifolia juices

Tested microorganisms

The tested microorganisms are part of the collection of the Laboratory of Biology and Molecular typing in Microbiology. The ten tested strains include five (05) gram positive bacteria (Staphylococcus aureus ATCC 29213, Staphylococcus epidermidis T22695, Micrococcus luteus ATCC 10240, Streptococcus oralis and Enterococcus faecalis ATCC 29212) and five (05) gram negative bacteria (Pseudomonas aeruginosa ATCC 27853, Proteus mirabilis 24974, Proteus vulgaris 25015, Escherichia coli ATCC 25922, Escherichia coli O157 and Salmonella typhi R 30951401).

Susceptibility of microorganisms to Morinda citrifolia juices

It was made according to the well diffusion method described by Bauer et al. (1966). From young reference strains (18–24 h), an isolated colony was collected and homogenized in 1 ml of Muller Hinton before being incubated for 18–24 h at 37 °C. From this culture, 106 CFU/ml inoculum was obtained by dilution. One ml of the inoculum was used to flood on Muller Hinton petri dishes. After seeding, the wells were thoroughly impregnated with 30 µl of M. citrifolia juices (fresh and fermented). The impregnated dishes were left for 15–30 min at room temperature (25 °C ± 2 °C) for pre-diffusion of the substances before being incubated at 37 °C (Adesokan et al., 2007). The diameters of the possible inhibition zones were measured using a graduated ruler after an incubation time of 24–48 h. The experiment was performed in duplicate.

Determination of minimum inhibitory concentration (MIC))

The minimum inhibitory concentration (MIC) was determined by the tube dilution method used by Dah-Nouvlesounon et al. (Dah-Nouvlessounon et al., 2015) with a visual assessment of the microorganisms growth after 24 h of incubation. For this, bacterial inoculum (106 CFU/ml) was brought into contact with a dilution range of plant juices. Thus, a series of 10 test tubes numbered T1 to T10, 1 ml of sterile distilled water was introduced in the tubes T2-T10. Into all tubes, 1 ml inoculum added to 106 CFU / ml of nutrient broth MH. All tubes containing a final volume of 2 ml were incubated at 37 °C. After 24 h of incubation, the turbidity of the tubes was examined in relation to the control tube T10.

Determination of minimum bactericidal concentration (MBC)

It was made in conjunction with the MIC determination. The MIC tubes to high concentrations were seeded using a platinum loop on petri dishes containing MH agar medium. These boxes were incubated at 37 °C for 24 h. The concentration of the juices that does not show any microbial growth represents the minimum bactericidal concentration (MBC).

Statistical analysis

Data was entered and processed in MS Office Excel 2016 spreadsheet. These data were then subjected to an analysis of variance (ANOVA) using the SPSS software with a significance rate p < 0.05.

Results

Phytochemical screening

The phytochemical investigation revealed mainly the presence of some large chemical groups both in the fermented and fresh fruit. As summarized in Table 1, the main chemical group detected are glycosides, polyphenols, and alkaloids. In addition, it was observed that the composition is not influenced by the fermentation stat of the juice. Thus, all the chemical compounds observed in the fresh juice were in the fermented one. To end, compounds such as anthocyanin, coumarines, anthraquinones, triterpenoids, steroids, cardenolides, cyanogenic derivatives, free anthracene, C-heterosides, mucilage.
Table 1

Phytochemical composition of M. citrifolia fruits juice.

Chemical compoundsFresh juiceFermented juice
Alkaloids++
Catechic tannins++
Gallic tannins++
Flavonoids++
Anthocyanin
Leuco-anthocyanin++
Coumarin
Anthra-quinone
Triterpenoids
Steroids
Cardenolids
Cyanogenic derivatives
Saponosids++
Reducing compounds++
Free anthracene
O-heterosids++
C-heterosids
Mucilage

–: absence; +: presence.

Phytochemical composition of M. citrifolia fruits juice. –: absence; +: presence.

Anti-radical activity of fresh and fermented M. citrifolia fruit juice

The results of the anti-radical activity of fresh and fermented fruit juice is shows in Table 2. Analysis of this table reveals that fresh fruit juice is more active (IC50 = 0.024 mg/ml) than ascorbic acid (IC50 = 0.027 mg/ml) because it has the lowest IC50. In addition, the fermented fruit juice is less active (IC50 = 0.047 mg/ml) than ascorbic acid. The activity of the fresh juice is about twice higher that fermented one (Table 2). The same observation was made for the effective juice concenraition reducing 50% of 2,2-diphenyl-1picrylhydrazyl (DPPH). Thus, the fermentation could be responsible for this difference in activity observed between the two fruit juices in spite of their identical phytochemical composition.
Table 2

Values of the anti-radical activity of M. citrifolia juices and reference molecule.

IC50 (mg/ml)EC50 (mg/ml)Anti-radical Activity
Ascorbic acid0.0271.3537
Fresh M. citrifolia fruit juice0.0241.241.67
Fermented M. citrifolia fruit juice0.0472.3521.28

IC50: Concentration of juice reducing 50% of DPPH; EC50: Effective juice concentration reducing 50% of the DPPH activity.

Values of the anti-radical activity of M. citrifolia juices and reference molecule. IC50: Concentration of juice reducing 50% of DPPH; EC50: Effective juice concentration reducing 50% of the DPPH activity.

Antibacterial activity of M. citrifolia juice

The mean inhibition diameters induced by our two M. citrifolia fruit juices on the tested strains are shown in Fig. 1. Diameters vary significantly depending on strain and type of M. citrifolia juice (p < 0.001). Thus, at 20 mg/ml, both juices have no effect on Micrococcus luteus and Salmonella typhi. However, both fruit juices inhibited the growth of strains such as Staphylococcus aureus, Pseudomonas aeruginosa, Proteus mirabilis, Staphylococcus epidermidis, Proteus vulgaris, Streptococcus oralis, Enterococcus faecalis and Escherichia coli with average inhibition diameters ranging from 10.0 cm to 14.5 cm for M. citrifolia fresh juice and from 9.5 cm to 12.0 cm for fermented juice. In addition, for each of these strains, the average inhibition diameter of fresh juice is greater than or equal to that of fermented juice. Thus, fresh juice is more active than three-month juice.
Fig. 1

Average inhibitory diameters of M. citrifolia juices ten bacterial strains. ns: not significant, *: p < 0.05, **: p < 0.01,***: p < 0.001.

Average inhibitory diameters of M. citrifolia juices ten bacterial strains. ns: not significant, *: p < 0.05, **: p < 0.01,***: p < 0.001.

Minimum inhibitory (MIC) and bactericidal (MBC) concentration of M. Citrifolia juices

Table 3 shows the minimum inhibitory (MIC) and bactericidal (MBC) Concentrations of the two M. citrifolia fruit juices. MIC values range from 2.5 to 5 mg / ml, while CMB values range from 10 to 20 mg/ml. The reports (MBC/MIC) show that both juices have bacteriostatic effects on strains. Fresh juice has a bacteriostatic effect on Staphylococcus epidermidis and Escherichia coli, while fermented juice induce bacteriostatic effect on Staphylococcus epidermidis, Streptococcus oralis and Enterococcus faecalis.
Table 3

Minimum inhibitory and bactericidal concentrations (mg/ml) of M. citrifolia juices.

Fresh juice
Fermented juice
MICMBCMBC/MICMICMBCMBC/MIC
Staphylococcus aureus2.5˃20ND5˃20ND
Pseudomonas aeruginosa2.5˃20ND2.5˃20ND
Proteus mirabilis2.5˃20ND5˃20ND
Micrococcus luteus˃20˃20ND˃20˃20ND
Staphylococcus epidermidis52045204
Proteus vulgaris5˃20ND5˃20ND
Streptococcus oralis2.5˃20ND2.5208
Enterococcus faecalis2.5˃20ND2.5104
Escherichia coli2.52085˃20ND
Salmonella typhi˃20˃20ND˃20˃20ND

ND: Not Determine.

Minimum inhibitory and bactericidal concentrations (mg/ml) of M. citrifolia juices. ND: Not Determine.

Discussion

The present study informed on the phytochemical composition, antioxidant and antibacterial activities of the fruit juice of Morinda citrifolia. Thus, the major groups of secondary metabolites observed on that juice are polyphenols, alkaloids and glycosides. These results are consistent with those of several authors who have worked on the fruits and leaves of this plant (Phakhodee, 2012, Wang and Su, 2001). These authors revealed in their study the presence of alkaloids, phenolic compounds, and glycosylated irideous. We note the presence of glycosylated irideous not found in our study. This relative difference could be related to climate and soil variation in both study areas (Houghton et al., 1998, Cybulski et al., 2000, Shen et al., 2008) or to the plant organ used. The total absence of anthocyanins significantly reduces the toxicological risk associated with the use of juice (Bruneton, 2009, Ortuno et al., 2006). Indeed, these compounds are responsible for toxicity due to the production of cyanide ions after ingestion and expressed by acceleration and then amplification of heart rate, respiratory depression, dizziness, impaired consciousness and even coma (Bruneton, 2009). The composition of secondary metabolites thus clearly explains the traditional use of Morinda citrifolia given the biological activities of the polyphenols and alkaloids contained therein (Mesia et al., 2005). Evaluation of anti-radical activity according proves that fresh fruit juice is more active than ascorbic acid. Indeed, the EC50 of ascorbic acid is lower than that of fresh fruit juice. Ascorbic acid is then less active than the fresh juice of M. citrifolia. These results are consistent with those of Wang and Su (2001) who showed that the antioxidant activity of M. citrifolia fruits is 2.8 times greater than that of ascorbic acid. For fermented fruit juice, our results suggest that fermented fruit juice from M. citrifolia is less active than fresh fruit juice. Indeed, the EC50 of ascorbic acid is lower than that of fermented fruit juice and higher than that of fresh juice. Fresh fruit juice is then more active than fermented fruit juice. Fermentation therefore significantly reduces the anti-radical activity of M. citrifolia fruit juice. These results are consistent with those of Yang et al. (2007), which demonstrated that fermentation could reduce the anti-radical activity of M. citrifolia fruits by up to more than 90%. In fact, after two weeks, the initial antioxidant activity of fresh fruit juice dropped significantly and more gradually from two weeks to about three months. Thus, on day 4, this decrease in activity was estimated at 40% for conservation at 24 °C and then at 70% when conservation is made between 28 °C and 31 °C. In addition, the juice lost more than 90% of its antioxidant activity when conservation is done for three months under these two different conditions. The antibacterial activity of the two fruit juices of M. citrifolia on the ten (10) reference strains indicates that the two fruit juices are active not only on Gram-positive strains (Staphylococcus aureus, S. epidermidis, Streptococcus oralis and Enterococcus faecalis) but also on gram-negative strains (Pseudomonas aeruginosa, Proteus mirabilis, P. vulgaris and Escherichia coli). These results are consistent with those of Srinivasahan and Durairaj (2014) who demonstrated the inhibitory effect of M. citrifolia fruit extracts on E. coli; Pseudomonas aeruginosa, B. subtilis and S. aureus. However, they are not consistent with those obtained by Jai Sunder et al. (2011) who noticed a lack of activity of Morinda citrifolia juice on S. aureus. This difference in activity would certainly be due to the phenology of the plant species (Cybulski et al., 2000, Shen et al., 2008, Houghton and Amala, 1998). The greatest antibacterial activities were obtained with fresh juice on Pseudomonas aeruginosa (14.5 ± 2.12 mm) followed by Escherichia coli (12.75 ± 1.06 mm). The lowest activities were obtained with fermented juice on Enterococcus faecalis 10 mm and Staphylococcus aureus (9.5 ± 2.12 mm). These results are consistent with those of Esath et al. (2012) who demonstrated that M. citrifolia fruit juice has more antibacterial activity on Gram negative than on Grams positive bacteria. Since Gram-negative strains are much more sensitive than Gram-positive strains, it is inferred that the accumulation of peptidoglycan layers by Gram-positive strains would be responsible for this bacterial resistance observed in Gram + (Basri and Fan, 2005, Vital and Rivera, 2009). In addition to the fact that the greatest antibacterial activities were observed with fresh fruit juice, we also noticed that for each of the eight strains for which both juices had activity, the inhibition diameter of fresh juice is either greater than or equal to that of fermented juice. It clears that fresh fruit juice is more active than fermented. Thus, the present study shows that fermentation could also reduce not only the antioxidant activity but also the antibacterial activity of the fruit juice of Morinda citrifolia. The different minimum inhibitory concentration values guarantee the use of M. citrifolia fruit juice in the treatment of infectious diseases (Jayaraman et al., 2008). The results of our study are consistent with those of previous studies that suggest that tannins and flavonoids may allow the extract to overcome the bacterial cell wall barrier (Anyasor et al., 2011).

Conclusion

The fruits of M. citrifolia are excellent sources of antioxidants and polyphenols. The anti-radical activity of fresh fruit juice is more important than that of fermented juice. Storing noni fruit juice at room temperature can significantly reduce its anti-radical activity. Thus, for the maximum anti-radical potential of fruits of M. citrifolia, refrigeration and freezing of noni juice is strongly recommended.

Data availability statement

The data are available from the corresponding author upon request.

Funding statement

This was a non-funded project; the principal investigators used their own funds to support the data collection and logistics.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
  1 in total

1.  Investigation of Morinda citrifolia Activities through Pinoresinol and α-EG Related Gene Expression.

Authors:  Runglawan Sudmoon; Sanit Kaewdaungdee; Unchaleeporn Ameamsri; Tawatchai Tanee; Pornnarong Siripiyasing; Warin Wonok; Arunrat Chaveerach
Journal:  Plants (Basel)       Date:  2022-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.